Seamus Pharmaceutical turned into a public organization in 2014 and recorded its offers in the Indian stock trades in 2016. As well as being the market chief in Semi-Synthetic Penicillins, it has a presence in key restorative fragments like neurosciences, cardiovascular, hostile to retrovirals, enemies of diabetics, gastroenterology and cephalosporins, among others.
For Job Applications: hr@seamus.com